B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 91,907 shares of the semiconductor company's stock, valued at approximately $46,541,000. B. Metzler seel. Sohn & Co. Holding AG owned 0.06% of Synopsys as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. Capital World Investors lifted its stake in shares of Synopsys by 12.5% in the first quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company's stock worth $4,211,892,000 after acquiring an additional 818,485 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Synopsys by 39.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company's stock worth $3,050,441,000 after purchasing an additional 1,514,449 shares during the period. Swedbank AB boosted its stake in shares of Synopsys by 1.4% in the 2nd quarter. Swedbank AB now owns 1,866,133 shares of the semiconductor company's stock valued at $1,110,461,000 after purchasing an additional 25,999 shares during the last quarter. Van ECK Associates Corp increased its position in shares of Synopsys by 26.5% during the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company's stock worth $791,923,000 after buying an additional 335,993 shares during the period. Finally, Janus Henderson Group PLC raised its stake in Synopsys by 6.5% during the first quarter. Janus Henderson Group PLC now owns 1,055,290 shares of the semiconductor company's stock worth $603,016,000 after buying an additional 63,966 shares during the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts have commented on SNPS shares. Needham & Company LLC reaffirmed a "buy" rating and set a $640.00 price target on shares of Synopsys in a research report on Tuesday, October 22nd. Robert W. Baird raised their target price on Synopsys from $661.00 to $663.00 and gave the stock an "outperform" rating in a research note on Thursday, August 22nd. Loop Capital assumed coverage on Synopsys in a research note on Monday, November 11th. They issued a "buy" rating and a $675.00 price target on the stock. Berenberg Bank started coverage on shares of Synopsys in a research report on Tuesday, October 15th. They set a "buy" rating and a $660.00 price objective for the company. Finally, Mizuho started coverage on shares of Synopsys in a research report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 target price on the stock. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $649.82.
Read Our Latest Report on SNPS
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 10,293 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $553.89, for a total value of $5,701,189.77. Following the completion of the transaction, the chief executive officer now directly owns 62,568 shares of the company's stock, valued at approximately $34,655,789.52. This trade represents a 14.13 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.66% of the stock is owned by insiders.
Synopsys Stock Performance
Shares of Synopsys stock traded up $10.04 on Tuesday, hitting $534.02. The company had a trading volume of 570,827 shares, compared to its average volume of 1,057,257. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38. The stock has a 50 day moving average of $515.34 and a 200-day moving average of $545.52. The stock has a market capitalization of $82.03 billion, a price-to-earnings ratio of 54.35, a P/E/G ratio of 3.18 and a beta of 1.08.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, August 21st. The semiconductor company reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.28 by $0.15. The business had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.52 billion. Synopsys had a return on equity of 22.09% and a net margin of 24.06%. The business's revenue was up 12.7% on a year-over-year basis. During the same period last year, the business earned $2.17 EPS. Equities analysts anticipate that Synopsys, Inc. will post 9.45 earnings per share for the current year.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.